<DOC>
	<DOC>NCT02468401</DOC>
	<brief_summary>There is a pressing need to find effective strategies for the prevention of contrast induced nephropathy in patients with advanced renal dysfunction. The current study was designed to assess the efficacy of a new protocol for preventing contrast induced nephropathy in patients with advanced renal dysfunction undergoing coronary interventions</brief_summary>
	<brief_title>Prevention of Contrast Induced Nephropathy in Patients With Advanced Renal Dysfunction Undergoing Coronary Interventions</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<criteria>Patients with estimated glomerular filtration rate&lt;45ml/min undergoing coronary angiography due to one of the following indications in accordance with the 2014 guidelines: 1. Elective coronary angiography due to symptoms suggestive for angina with a positive noninvasive ischemia assessment of â‰¥10% of left ventricle. 2. Non STelevation acute coronary syndrome with a GRACE score&gt;110 Patients on dialysis or those planned for dialysis in the next 3 months. Patients with STelevation myocardial infarction No symptoms or signs of heart failure Treatment with IV diuretics during the 48 hours prior to enrolment Patients with acute renal failure (Creatinine raise of at least 0.3mg/dl from )baseline Patients post coronary artery bypass surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>